Blood Disease Drugs Industry Forecasts - China Focus
- ASI3276367
- 145 Pages
- October 2019
- Pharmaceuticals
Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.
This new study focuses on industry trends and forecasts with historical data (2008, 2013 and 2018) and long-term forecasts through 2023 and 2028 are presented.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases.
Asia Market Info & Dev Co. is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. We have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
Market Trends
Technology Development
Market Development
Major Industry Development
Regional Development
Enterprise Development
Labor Market Development
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
Overview
Demand of Blood Disease Drugs by Region
Blood Disease Drugs Sales Volume
Anemia Treatment Drugs
Mecobalamin
Cobamamide
Ferrous Succinate
Leucogen
Neutropenia and Agranulocytosis Treatment Drugs
VitamineB4
Batilol
Inosine
Deoxyribonucleotide
Adrenocortical Hormone
Granulocyte Colony-Stimulating Factor(G-CSF)
Leukemia Treatment Drugs Sales Volume
Interferon
Imatinib
Rituximab
Pirarubicin
Hydroxycampothecin
Other Blood Disease Drugs Sales Volume
Blood Disease Drugs Imports
Anemia Treatment Drugs
Mecobalamin
Cobamamide
Ferrous Succinate
Leucogen
Neutropenia and Agranulocytosis Treatment Drugs Imports
VitamineB4
Batilol
Inosine
Deoxyribonucleotide
Adrenocortical Hormone
Granulocyte Colony-Stimulating Factor(G-CSF)
Leukemia Treatment Drugs Imports
Interferon
Imatinib
Rituximab
Pirarubicin
Hydroxycampothecin
Other Blood Disease Drugs Imports
Pricing Trends
ULIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
Total Blood Disease Drugs Sales Volume
Blood Disease Drugs Major Producer and Their Market Share
Anemia Major Producer and Their Market Share
Anemia Treatment Drugs Sales Volume by Drugs Classification
Anemia Treatment Drugs Major Producer and Their Market Share
Mecobalamin Major Producer and Their Market Share
Cobamamide Major Producer and Their Market Share
Ferrous Succinate Major Producer and Their Market Share
Leucogen Major Producer and Their Market Share
Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share
Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
VitamineB4 Major Producer and Their Market Share
Batilol Major Producer and Their Market Share
Inosine Major Producer and Their Market Share
Deoxyribonucleotide Major Producer and Their Market Share
Adrenocortical Hormone Major Producer and Their Market Share
Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share
Leukemia Treatment Drugs Major Producer and Their Market Share
Leukemia Treatment Drugs Sales Volume by Drugs Classification
Interferon Major Producers and Their Market Share
Imatinib Mesylate Major Producer and Their Market Share
Rituximab Major Producer and Their Market Share
Pirarubicin Major Producer and Their Market Share
Hydroxycampothecin Major Producer and Their Market Share
Blood Disease Drugs Import
Anemia Treatment Drugs Import Volume by Drugs Classification
Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
Leukemia Treatment Drugs Import Volume by Drugs Classification
ULIST OF CHARTS
I. INTRODUCTION
Blood Disease Drugs Sales Volume
II. BUSINESS ENVIRONMENT
China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
Blood Disease Drugs Sales Volume
Worldwide Blood Disease Drugs Demand by region
Anemia Major Producer and Their Market Share
Anemia Treatment Drugs Sales Volume by Drugs Classification
Mecobalamin Sales Volume and Market Share
Cobamamide Sales Volume and Market Share
Ferrous Succinate Sales Volume and Market Share
Leucogen Sales Volume and Market Share
Neutropenia and Agranulocytosis Treatment Drugs Sales Volume and Market Share
Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
VitamineB4 Sales Volume and Market Share
Batilol Sales Volume and Market Share
Inosine Sales Volume and Market Share
Deoxyribonucleotide Sales Volume and Market Share
Adrenocortical Hormone Sales Volume and Market Share
Granulocyte Colony-Stimulating Factor(G-CSF) Sales Volume and Market Share
Leukemia Treatment Drugs Sales Volume and Market Share
Leukemia Treatment Drugs Sales Volume by Drugs Classification
Interferon Sales Volume and Market Share
Imatinib Mesylate Sales Volume and Market Share
Rituximab Sales Volume and Market Share
Pirarubicin Sales Volume and Market Share
Hydroxycampothecin Sales Volume and Market Share
Other Blood Disease Drugs Sales volume and Market Share
Blood Disease Drugs Import Volume
Anemia Import Volume and Market Share
Anemia Treatment Drugs Import Volume by Drugs Classification
Mecobalamin Import Volume and Market Share
Cobamamide Import Volume and Market Share
Ferrous Succinate Import Volume and Market Share
Leucogen Import Volume and Market Share
Galanthamine Import Volume and Market Share
Neutropenia and Agranulocytosis Treatment Drugs Import Volume and Market Share
Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
VitamineB4 Import Volume and Market Share
Batilol Import Volume and Market Share
Inosine Import Volume and Market Share
Deoxyribonucleotide Import Volume and Market Share
Adrenocortical Hormone Import Volume and Market Share
Granulocyte Colony-Stimulating Factor(G-CSF) Import Volume and Market Share
Leukemia Treatment Drugs Import Volume and Market Share
Leukemia Treatment Drugs Import Volume by Drugs Classification
Interferon Treatment Drugs Import Volume and Market Share
Imatinib Mesylate Treatment Drugs Import Volume and Market Share
Rituximab Treatment Drugs Import Volume and Market Share
Pirarubicin Treatment Drugs Import Volume and Market Share
Hydroxycampothecin Treatment Drugs Import Volume and Market Share
Other Blood Disease Drugs Import Volume and Market Share
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
